Actively Recruiting
Voll Degradable Shoulder Spacer FIH Study
Led by Voll Medical Technologies Ltd. · Updated on 2026-03-06
20
Participants Needed
4
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).
CONDITIONS
Official Title
Voll Degradable Shoulder Spacer FIH Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Full thickness massive rotator cuff tear
- Male or female patients 50 years of age or older
- Generally in good health and independent
- Able to comply with all post-operative evaluations and visits
You will not qualify if you...
- History of drug or alcohol abuse within 1 year before enrollment
- Currently participating in any other investigational clinical study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Assuta Ashdod Hospital
Ashdod, Israel
Actively Recruiting
2
Ichilov (Sourasky Medical Center)
Tel Aviv, Israel
Not Yet Recruiting
3
Humanitas Gavazzeni Castelli
Bergamo, Bergamo, Italy, 24125
Not Yet Recruiting
4
Istituto Ortopedico Rizzoli
Bologna, Bologna, Italy, 40136
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here